[1]
M. S. Larsen, K. Bjerre, A. Giobbie-Hurder, A.-V. Lænkholm, K. L. Henriksen, and B. Ejlertsen, “Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy”, AO, vol. 51, no. 6, pp. 781–789, Jul. 2012.